CD4+ splenocytes coming from young tacalcitol-treated mice and stimulated ex vivo to induce Th17 cells produced higher levels of IL-17A than those from untreated control mice, whereas the opposite effect was observed in aged OVX mice.24 The effect of IL-17 varies depending on the stage of tumor development. The gene discussed is IL17A; the disease is neoplasm.